TY  - JOUR
AU  - Raggi, Paolo
AU  - Bellasi, Antonio
AU  - Bushinsky, David
AU  - Bover, Jordi
AU  - Rodriguez, Mariano
AU  - Ketteler, Markus
AU  - Sinha, Smeeta
AU  - Salcedo, Carolina
AU  - Gillotti, Kristen
AU  - Padgett, Claire
AU  - Garg, Rekha
AU  - Gold, Alex
AU  - Perelló, Joan
AU  - Chertow, Glenn M
PY  - 2019
DO  - 10.1161/CIRCULATIONAHA.119.044195
UR  - http://hdl.handle.net/10668/14665
T2  - Circulation
AB  - The high cardiovascular morbidity and mortality in patients with end-stage kidney disease could be partially caused by extensive cardiovascular calcification. SNF472, intravenous myo-inositol hexaphosphate, selectively inhibits the formation and...
LA  - en
PB  - Lippincott Williams & Wilkins
KW  - Calcium
KW  - Randomized controlled trials as topic
KW  - Renal insufficiency, chronic
KW  - Vascular calcification
KW  - Aged
KW  - Aortic Valve
KW  - Coronary Artery Disease
KW  - Disease Progression
KW  - Double-Blind Method
KW  - Durapatite
KW  - Europe
KW  - Female
KW  - Heart Valve Diseases
KW  - Humans
KW  - Infusions, Intravenous
KW  - Kidney Failure, Chronic
KW  - Male
KW  - Middle Aged
KW  - Phytic Acid
KW  - Renal Dialysis
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
KW  - Vascular Calcification
TI  - Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study.
TY  - research article
VL  - 141
ER  -